Invasive fungal aspergillosis is a leading cause of morbidity and mortality in many species
including avian species such as common ravens (Corvus corax). Methods were developed …

Aspergillosis is a major cause of mortality in captive birds and its prognosis is often poor due
to treatment failure. Voriconazole is a novel triazole antifungal agent that may be useful for …

Doses of 12· 5 mg voriconazole/kg bodyweight administered every 12 hours by crop gavage
to six falcons for 14 days provided peak plasma concentrations of more than 1 μg/ml, but the …

Voriconazole, a highly potent triazole antifungal agent with high in vitro activity against a
wide variety of fungal pathogens, appears to be an option for the treatment of aspergillosis in …

Voriconazole is currently recommended as first choice treatment for aspergillosis in birds. An
evaluation of the influence of food intake was performed with twelve African grey parrots …

Aspergillosis is a condition causing serious morbidity and mortality in captive penguins and
other bird species. It can be treated with antifungal drugs, such as voriconazole. However …

OBJECTIVE To determine the pharmacokinetics of voriconazole after single IV or orally
administered boluses in common ravens (Corvus corax). ANIMALS 8 healthy common …

The pharmacokinetics of voriconazole (VRC) administered intravenously (IV) or orally (PO;
with and without liquid diet) to mallard ducks were studied. Dose range, drug bioavailability …

ABSTRACT Voriconazole (Vfend®, Pfizer) is a novel, highly potent triazole antifungal agent
with high in vitro activity against a wide variety of fungal pathogens. The present study was …

OBJECTIVE To determine the pharmacokinetics of voriconazole administered PO with or
without food to red-tailed hawks (Buteo jamaicensus) and whether any observed variability …